Biophage Announces New Development Breakthrough in its Biosensors Technology

21-Apr-2005

Biophage Pharma Inc. announced a new development in its biosensors technology. The Biosensor unit is now able to detect the three most important bacterial pathogens in drinking water : E. coli 0157:H7, Campylobacter and Salmonella. This is the first time that the Biosensor is proven to be efficient in the detection of anaerobic bacteria (i.e., bacteria that are capable of growing in the absence of oxygen).

"We are extremely pleased by this new capability within our strategic product focus. The most recent developments provide further proof of the versatility of our Biosensor and its ability to detect the three major waterborne bacterial pathogens that are most frequently associated with drinking water. Our product will find wide-ranging applications for bacterial monitoring in source and finished waters in both developed and developing countries", stated Dr Rosemonde Mandeville, President and CEO of Biophage Pharma Inc. "The ability to detect anaerobic bacteria is a novel feature that puts us one step closer to having a commercially viable product that redefines our ability to assess health risks associated with drinking water from indicator-based risk (Coliforms, etc.) to pathogen-specific monitoring", continued Dr Mandeville.

The Company had previously announced the Biosensor's ability to detect 5-10 bacteria in a 1 ml sample without any pre-enrichment and to simultaneously screen up to 60 samples for different types of bacteria. The unique feature of this product is its ability to detect not only the presence, but also the viability of these pathogens. This latest advance will open the application of this Biosensor to monitoring the presence of waterborne pathogens in drinking water.

https://www.bionity.com/en/news/45327/biophage-announces-new-development-breakthrough-in-its-biosensors-technology.html